A team led by Prof. Wuran Wei from West China Hospital of Sichuan University and Dr. Dechao Feng from the Division of Surgery ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Background: Lung adenocarcinoma (LUAD) is one of the most common malignant tumors globally, characterized by poor prognosis and high mortality. Abnormal fatty acid metabolism plays a crucial role in ...

Figure 11. Proposed mechanism of DSF against renal fibrosis via inhibition of PIK3/Akt/mTOR signaling pathway. TGF-β activates the PI3K pathway, leading to the activation of Akt. Activated Akt then ...

PI3K 抑制剂能否解乳腺癌内分泌治疗耐药的燃眉之急？以 PI3K 抑制剂为基础的联合治疗对于内分泌耐药人群的治疗前景如何？本文中，笔者与您一同来探讨这些问题，旨在为临床诊疗提供思路与启发。

Klamath Community College’s Apprenticeship Center was recently awarded a $338,395 Energy Efficiency Training Grant from the Oregon Department of Energy (ODOE) to expand the growth of the college ...